Bluejay Diagnostics, Inc. (BJDX) Stock

Bluejay Diagnostics, Inc., a leading diagnostic company based in Acton, Massachusetts, specializes in the development and commercialization of innovative products designed for patient triage, diagnosis, and disease progression monitoring across the United States.

At the forefront of its offerings is the Symphony platform, a cutting-edge technology that integrates the Symphony Fluorescence Immuno-analyzer. This platform revolutionizes blood processing, biomarker isolation, and immunoassay preparation through non-contact centrifugal force, enhancing efficiency and accuracy in diagnostic procedures. Complementing this platform is the Symphony Cartridge Library, which features a range of essential reagents and components crucial for diagnostic applications.

Bluejay Diagnostics is dedicated to expanding its diagnostic portfolio with groundbreaking products like the ALLEREYE diagnostic test. This Point-of-Care (POC) device plays a pivotal role in diagnosing allergic conjunctivitis, providing rapid and reliable results to healthcare professionals and patients alike. Beyond ocular diagnostics, the company is actively developing biomarkers such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure, underscoring its commitment to advancing diagnostic capabilities across various disease states. Moreover, Bluejay Diagnostics holds a significant license and supply agreement with Toray Industries, Inc., facilitating the production and distribution of protein detection chips to further augment its diagnostic capabilities.